Dyno Nobel Limited (DNL) Earnings Call Transcript
November 8, 2026
Earnings Call Speaker Segments
Good morning, and welcome to Dyno Nobel Limited's 2026 Full Year Results Briefing. This is Tom Dixon speaking, and I'm joined this morning by our CEO and Managing Director, Mauro de Moraes; and our Group CFO, Nitesh Naidoo. The materials we will be covering today have been lodged with the Australian Securities Exchange and are available on the ASX and Dyno Nobel websites. At the end of the presentation, we'll have time for questions, and an audio recording will also be made available on the company's website. I'll draw your attention to the disclaimer on Slide 2 and Slide 3 of the presentation. And before we move into the main presentation, I'd like to begin with an acknowledgment of country. I acknowledge the first peoples of the land, sea and waters across the various locations that we are living and working from today. I pay my respect to elders past and present. Thank you. I'll now hand over to Mauro.
Thank you, Tom. Good morning, everyone, and welcome. Nitesh and I are pleased to present Dyno Nobel's 2026 full year results. I'll start with our 2026 highlights and the outlook for fiscal year '27. Then I'll cover our progress on safety, our transformation and the next drivers of growth, new markets, premium technology and energetics. Nitesh will then take you through our financial performance, capital investments, balance sheet and shareholder returns. I'll return with our closing remarks on why we believe in Dyno Nobel's future, then we'll take your questions. Let me begin with the results and how we are building a stronger base for growth. Fiscal year '26 was a strong year for Dyno Nobel. Our explosives business delivered a record result with underlying EBIT of $485 million, up 12% year-on-year. We delivered on our financial year '26 commitments. Our transformation program generated $51 million in net benefits. At year-end, our exit run rate stood at 70% of our $300 million EBIT uplift ambition. We completed our move to a pure-play explosives company. The sale of Fossil fuel marked the final step in separating our fertilizer business. Safety and reliable delivery remain our foundation. In the second half, we recorded 0 process safety incidents and saw a clear improvement in TRIFR. In our growth markets, we won new customer projects in Ghana, Tanzania, Brazil, Canada and Western Australia. Our privileged assets and vertical integration continue to create advantage. The Moranbah debottlenecking project is complete and Cheyenne remains on track for completion in the first quarter of financial year '27. We also made tangible progress in Energetics with approximately USD 1 billion of U.S. government funded TNT and IMAX projects now progressing at Graham, Kentucky. Such results keeps us on track for a $600 million EBIT ambition in financial year '28. By the end of financial year '27, we expect our exit run rate to reach about 85% to 95% of our uplift ambition. Safety comes first today and always. Our full year TRIFR was 1.01 compared with 0.95 in financial year '25. That's not where we want to be, but it does not tell the full story of our progress throughout the year. TRIFR fell from 125 in the first half to 0.77 in the second half. Strong leadership in the field, early identification of hazards and a sharper focus on high-risk work began to deliver results. Process safety also improved. Incidents fell by 81%, and we recorded 0 process safety incidents in the second half. No incidents were classified as serious harm in financial year '26. At 80% of our sites, there were no recordable injuries. Injury severity fell by 41%. We also recorded no major environmental incidents. We welcome this progress, but the work is not done. Our TRIFR target remains 0.76. We will keep building the leadership, systems and behaviors required to achieve zero harm for everyone everywhere. Now to the financial results. Group revenue was $3.941 billion. EBIT was $504 million, excluding individually material items. Our statutory profit after tax, including IMIs, was $66 million. That compares with a loss of $53 million in the previous period. Group revenue and earnings reduced year-on-year as we reshaped our portfolio through the sale of the fertilizers. The keyest measure of the ongoing business is the Dyno Nobel explosives results. Explosives revenue rose 10% to $3.406 billion. EBITDA rose 8% to $759 million. Underlying EBIT increased 12% to a record $485 million. ROIC, excluding fertilizers, rose from 5.2% to 6.7%. This reflects a strong explosives business and the impact of turnarounds in financial year '25. We returned $574.4 million through our buyback program at an average price of $3.01 per share. We have announced a final dividend of $0.05 per share, bringing total financial year '26 dividends to $0.09 per share, $0.096 per share. At year-end, net debt-to-EBITDA was 2.1x within our policy range. For financial year '27, we expect underlying EBIT of about $515 million to $555 million, subject to the assumptions and risks set out in this presentation. The transformation program delivered $51 million in net benefits during financial year '26. Commercial actions made the largest contribution. New customer wins, repricing and wider use of our premium technology delivered $51 million. Priority growth markets added $19 million. Change to how we operate, buy and manufacture also delivered gains across our cost base. These gains were partially offset by $55 million in temporary headwinds and other impacts. This included about $40 million from foreign exchange and $11 million in added depreciation. Inflation also had an impact. Unplanned downtime at Cheyenne and supply limits from the Walla turnaround accounted for about $6 million. The core drivers of our transformation remain intact, better contracts, firm pricing discipline, stronger manufacturing and growth in markets where we can win are delivering results. In financial year '27, we expect another $30 million to $70 million in net transformation benefits. Priority growth markets offer the largest opportunity. New contracts will start in Africa and Latin America with further growth in Canada, Asia and WA. We expect a further $20 million to $30 million from our commercial actions. These include commercial customer wins, repricing, better product bundling and wider use of premium technology. Manufacturing, supply chain and procurement actions are expected to add up to $15 million. We will unlock more production capacity through debottlenecking and improved efficiency. About $25 million in offsets will reduce those gains. This includes the scheduled maintenance at Moranbah and our foreign exchange assumptions. In this table, you can see our progress since financial year '23. From financial year '24 to '26, we delivered $185 million in net transformation benefits. Commercial benefits totaled $154 million gross. Operations added $83 million and growth markets added $59 million. Against those gains, we had $111 million in offsets. Depreciation, stranded costs, inflation and temporary operating impacts are examples of such offsets. Underlying explosives EBIT rose from $300 million in financial year '23 to $485 million in financial year '26. We exit financial year '26 with a run rate of $510 million. That puts us at 70% of our $300 million uplift ambition. By the end of financial year '27, we expect that the run rate -- that run rate to reach about 85% to 95%. We remain on track for the $600 million ambition in financial year '28. This is not the result of any single action. It comes from stronger commercial delivery, lasting changes to our operations, disciplined growth and a more focused business. As we showed in our recent Investor Day, we see 5 powerful megatrends supporting long-term growth across our markets. Electrification and the energy transition are driving critical minerals demand with copper material moved expected to grow by around 50% from 2021 to 2031. Supply chain security is also driving investment with around $30 billion mobilized for critical minerals reshoring in the United States. At the same time, more than $1 trillion of AI-related infrastructure investment is projected over the next 3 to 5 years, supporting demand for commodities, material and energy. Declining ore grades down an estimated 6% to 8% are increasing the need for productivity, technology and technical expertise. And in Defense energetics, the market is expected to double by 2035, creating a compelling adjacent growth opportunity. Importantly, each of these trends aligns closely with our capabilities and competitive strengths we have, giving us confidence in the long-term outlook for our business. Our growth is gaining traction through customer wins in metals and in the priority regions we shared at our Investor Day. Metals rose 70% in '26 measured by revenue. The share of explosives revenue grew by 4 percentage points. In North America, metals revenues rose 29% as we brought in new customers. Canada delivered revenue growth of more than 40%, new operations, including Agnico Eagle's Hope Bay and Skeena's Eskay Creek. In Australia, we won more than 10 new hard rock sites over the past 12 months. We continue to grow our presence in WA. In Asia, the capital-light model is now operating in Malaysia. We see further opportunities in PNG, the Philippines and India. Across Africa and Latin America, we won 4 new sites, including projects in Ghana, Tanzania and Brazil. These wins show that we can achieve when we bring together global customer ties, strong local delivery and technology that sets us apart. In Africa and Latin America, we are moving from winning contracts to setting up operations and delivering services. In Ghana, services began in September at Anglo Global Santis, Obuasi and the Iduapriem operations. Local emotion production in Iduapreim'ss planned for the first quarter of financial year '27. In Tanzania, services at Geita are expected to begin as the on-site unit is brought into service this quarter. In Peru, we aim to bring the Ilo emotion plant into service also in the first quarter of financial year '27. In Brazil, operation at Vale's Fabrica site are also expected to begin before the end of calendar year. These leading global customers give us a firm base for growth in these regions. Our approach is disciplined and makes careful use of capital. Premium technology helps us deliver more value to customers, better quality revenue and stronger earnings. Electronic initiation system volumes increased 11% in financial year '26 as customers continue to convert from legacy systems and new customer wins supported further adoption. Our premium products earned margins about 1.2x those of standard products. They help customers improve productivity, rock fragmentation and operating performance. Use of Nobel Fire rose 19%. Customers are making greater use of digital tools to plan, carry out and improve their blasting. The aim is not simply sell more product. It's to deliver more value to customers and build earnings that are stronger and more resilient. The autonomous bench shows technology strategy in action, solving real problems for customers. The solution is designed to automate dipping, priming, loading and stemming while allowing operations to be supervised from a control room. This keeps people away from high-risk areas, supports continuous operations and uses data to deliver more consistent blasting results. The autonomous equipment has now been built. With our partner, Mariana Minerals, we plan the first site trial by mid-2027. This solution is a key part of a fully autonomous mining operation. Other customers are already showing early interest in the technology. This is a practical demonstration of how our proprietary technology, digital capability and customer partnerships can create a meaningful competitive advantage. Energetics opens a new path for growth alongside our core business. Our assets, expertise and operating systems gives a strong base to compete. At Graham, Kentucky, 2 U.S. government-funded projects are building that new growth platform. The TNT project is worth USD 435 million. The IMS project is worth USD 581 million. Together, they represent about $1 billion in government-funded investment at Graham. The IMX project is being delivered through Nitradyn, our 50-50 joint venture with Paligen, combining Dyno Nobel's manufacturing capability with Paligen's defense contracting expertise. The value goes beyond the new source of earnings. The TNT and IMX facilities will strengthen U.S. security of supply, increase vertical integration and reduce our reliance on imported critical raw materials. The model is designed to deliver recurring earnings through product margins on offtake or tolling fees on government demand. The TNT project is moving through detailed engineering, permits and site preparation. First production is expected in late 2028. First IMX production is expected by 2030. Our financial year '21 group ambition of $800 million EBIT includes about $30 million to $40 million from North American Energetics. At Graham, the IMX project takes us into Advanced Energetics material. The project includes 5 smaller plants, making materials such as RDX and HMX. These can be used on their own or as components of IMX-104. This gives us more ways to serve governments, defense contractors. It also allows us to supply raw materials for our own commercial use or for sale. In Europe, Von gives us an established base with a long history in energetics and deep technical expertise. European demand for energetics is expected to roughly double between 2026 and 2035. More manufacturing capacity will be needed. We are exploring a new energetics facility at Vonges. Offtake talks are moving forward with potential customers in Europe and NATO aligned customers. Process and engineering options remain under evaluation and the next stage will define the preferred concept, development pathway and commercial approach. We will remain disciplined and progress opportunities where our capabilities create a clear advantage and where the returns justify the investments. I will now hand over to Nitesh, who will cover the financials.
Thank you, Mauro, and good morning, everyone. In this section, I'll take you through the FY '26 financial performance, investing activities and the balance sheet. I'll finish with the FY '27 Dyno Nobel outlook. On Slide 22, FY '26 was a strong year for the Dyno Nobel business, and we exit the year on track to deliver the $600 million EBIT ambition in FY '28. We spoke to you about the next horizon of growth to FY '31 and our $800 million ambition, but recognize the first step is $600 million by FY '28. Underlying explosives EBIT increased 12% to $485 million, driven by record performances in DNA and DNAP. Our strategic joint ventures also performed strongly. JV income increased 16% year-on-year to $93 million and JV tax adjusted EBIT across the explosives business reached $518 million. I'll talk more about JV tax effect later in the section. The transformation program delivered $51 million of net benefits in FY '26, taking the exit run rate to 70% of the $300 million uplift ambition. Explosives revenue increased 10%, supported by long-term customer relationships and a forward contract order book of around 2x FY '26 revenue. That forward coverage does not include Energetics and provides a strong visibility over the underlying revenue base. Moving to '23. The business has built strong momentum since FY '23. Underlying EBIT has increased from $300 million to $485 million, representing compound annual growth of around 17%. ROIC has improved by approximately 90 basis points over the same period with FY '26 explosives ROIC at 6.7% -- underlying EPS for the explosives business has increased from around $0.07 in FY '23 to $0.18 in FY '26, supported by earnings growth and the share buyback program. Our forward contract value is an important metric for us. It reflects the trust our customers place in us and the resilience of our earnings through committed contracts. This stands at approximately 2x FY '26 revenue. Together, these indicators show the combination of transformation-led earnings growth, disciplined capital allocation, improving returns and strong revenue stability. Moving to Slide 24. At a group level, revenue was $3.9 billion, down 26%, reflecting the sale of Phosphate Hill in FY '26 and the IPF distribution business in FY '25. Explosives revenue was $3.4 billion, which grew 6% year-on-year with operating increasing -- operating margin increasing 3% to just over $1 billion. Group EBITDA, excluding individually material items, was $778 million and EBIT was $504 million. Within that result, Explosives EBIT increased 17% to $485 million, reflecting the underlying momentum of the transformation program and the impacts of the FY '25 turnaround in the comparator. NPAT, excluding individually material items, was $331 million. Individually material items were $265 million after tax, mainly relating to the sale of Phosphate Hill, fertilizer exit costs and the impairment of loans associated with the receivership of QPM, a gas supplier to DNAP. I want to reiterate that through comprehensive security arrangements, gas supply to Moranbah is secure, and we are working with the receiver to maintain a sustainable supply to Moranbah. After those items, statutory net profit was $66 million, up from a $53 million loss in FY '25. Moving to Slide 25. Now moving on to the underlying Explosives business. No adjustments have been made for FY '26 reported ex-IMI numbers. We have normalized for turnarounds in FY '25, which is why headline EBIT growth was 17%. Underlying Explosives EBIT increased 12% to $485 million with record performances from our 2 largest business units. Excluding foreign exchange impacts, Explosives revenue increased 14% and EBIT increased 16%. D&AP revenue increased 11% to $1.3 billion and EBIT increased 10% to $281 million. The Metals segment was the primary driver of growth contributing approximately 66% of the total revenue increase, supported by strategic customer wins and successful renewal of key contracts. DNA revenue increased 13% to $1.9 billion and EBIT increased 19% to $224 million. FX has impacted the translated results for D&A. In local currency, the performance is better reflected with revenue growth of 21%, operating margin growth of 8% and EBIT growth of 28%. The standout growth was supported by sales of surplus ammonium nitrate during a period of tight supply, the resumption of booster sales following T&T shortages in FY '25 and continued demand across key customer segments. Demand was also higher as several major customers entered periods of increased pre-stripping activities. The operating margin was impacted by tight AN markets in half 2 with higher third-party purchased AN to meet customer demand in the U.S. DNEL experienced a more challenging trading environment. Revenue reduced 12% to $287 million. This is mainly driven by the European performance, which was impacted by disruption to key shipping routes arising from the Middle East conflict, which constrained international exports as well as economic conditions in France and Turkey. LatAm declined 2% due to severe weather conditions in Chile. DEL EBIT reduced to $18 million, reflecting the revenue impacts mentioned, together with investments in market entry. This remains a strategic focus for Dyno Nobel with new customer mobilizations expected to recover this result. Across the group, transformation initiatives in pricing, procurement and operations delivered structural cost reductions and efficiency gains. JV income increased 16%, reflecting strong performance from our North American partners and record earnings from QNP for its financial year ended 30th June. JVs remain a vital part of our strategy, and it's important to note that the post-tax impact to our earnings diminish our EBIT and has a material impact due to the strategic choice of operations through JVs. This impact is $33 million in FY '26 due to the growth in this channel since FY '23 and into the future with our defense JV, Nitrodi. This needs to be considered for valuation purposes. We have included a slide in the appendix to illustrate this. On a tax-adjusted basis, total Exlusives EBIT was $518 million, up 12% from $464 million in FY '25. Moving to Slide 26. FY '26 capital expenditure was $282 million within our guidance range of $265 million to $285 million. The program included $124 million of sustenance CapEx, $60 million of digital and technology and $86 million of CapEx supporting customer growth. For FY '27, capital expenditure is expected to increase to approximately $370 million to $420 million. The range reflects scheduled turnaround expenditure, customer growth, technology investment and the next phase of our Energetics program. This includes approximately USD 40 million for the Cheyenne turnaround and approximately USD 20 million for defense and energetics investments. The FY '27 range also allows for potential customer wins and growth initiatives with capital continuing to be deployed selectively against expected returns and strategic priorities. These investments are consistent with the capital allocation framework we discussed at our Investor Day in September. Moving to Slide 27. Overall, the balance sheet remains solid with both ratings agencies acknowledging the improved credit quality post the completion of separation. We retain investment-grade credit ratings of BBB from S&P and Baa2 from Moody's, with both increased leverage headroom to 2.75x in the year. Trade working capital was 19.2% of revenue, broadly stable against 19.5% in FY '25, while cash conversion at 36% has been impacted by fertilizer separation and higher inventories to manage the volatility in the year. Going forward, we expect the long-term cash conversion post interest and tax to be in the range of 60% to 75%. Explosives earnings per share, excluding IMIs, increased 56% to $0.18, reflecting the transformation, non-turnaround year and the successful buyback program. This is clearly visible in the explosives ROIC, which improved to 6.7% from 5.2% in the prior year. Net debt was $1.5 billion and net debt-to-EBITDA was 2.1x within our 1.75 to 2.25 policy range. On-market buybacks returned $574 million through the program, purchasing 191 million shares at an attractive average price of $3. We have announced a final dividend of $0.05 per share, 50% franked, taking the total FY '26 dividends to $0.096 per share. Now turning to the outlook for FY '27 on Slide 28. We currently expect underlying EBIT in the range of approximately $515 million to $555 million. We expect underlying results to be weighted approximately 40% to the first half and 60% to the second half. The outlook assumes borrowing costs of approximately $105 million to $120 million, an effective tax rate of approximately 20% to 25% and capital expenditure, as mentioned, approximately $370 million to $420 million. It also assumes AUD to U.S. dollar exchange rate of $0.70, corporate costs of approximately $45 million to $50 million and an FY '27 transformation exit run rate of approximately 85% to 95% -- in Asia Pacific, we expect the benefit of higher Moranbah production volumes following debottlenecking, partly offset by the QMP turnaround in the first half. In North America, the Cheyenne turnaround is scheduled for the second half with debottlenecking projects at Cheyenne and LOMO expected to complete during FY '27. In EMEA and Latin America, we expect operations to scale in Ghana, Tanzania and Brazil. Net debt-to-EBITDA is expected to remain at the top end of our guided range of 1.75 to 2.25x. I'll now hand over to Mauro to close.
Thanks, Nitesh. Let me close with a clear message. These results show why we have confidence in Dyno Nobel's future. We are now a focused pure-play explosives business. We have resilient growth, strong contractual protections and leading positions in attractive markets. Safety and reliability comes first. They earn our customers' trust, support our performance and give us the foundation to grow. Long-term demand is working in our favor. The world needs critical resources, infrastructure and smarter mining solutions. We are building growth across multiple pathways, which include our established North America and Asia Pacific businesses, priority markets in Canada, Western Australia, Asia, Africa and Latin America. Our strength lies in what we bring together, premium technology, a network of privileged assets, deep customer ties and experienced people who can deliver. Our transformation is building stronger earnings, better margins and better ways of working. At every step, disciplined capital allocation guides our growth decisions. 2026 was a strong year. We completed our move to a pure-play explosives company and enter financial year '27 with clear momentum. The ambition is clear, $600 million in EBIT by financial year '28. We remain on track, and we are laying the foundations for the next phase of growth beyond financial year '28. Thank you for your time and your continued interest in Dyno Nobel. I'll now hand back to the operator. Operator, can you please remind callers how to ask a question in the Q&A?
[Operator Instructions] And your first question is from the line of Ramoun Lazar from Jefferies.
A couple of questions for me. Just maybe starting with the '27 guidance. If you could just talk through some of the end markets, some of the moving parts. I know corporate costs are higher than I think what the Street was expecting, perhaps there's some temporary factors in there as well. And then also your first half, second half split is more skewed to the second half than normal. Maybe just talk through that as well, please.
Yes. Thanks, Ramoun. Good to talk to you. Look, the second half, first half has to do with the turnaround on Cheyenne. Other than that, all the usual weather-related events in the first half remain. So we guided to that with and without the turnaround for people's reference. In terms of end markets, look, we still see strength in our core markets of Australia and U.S. So if I start with the U.S., we still see tight markets for ammonium nitrate. That hasn't changed, and we hope that we can see continued growth in that market. In Australia, we have seen, again, strength on the domestic markets. The market is very well balanced, probably as balanced as I've seen. And we see still spot trading when you look at the import parity at around $1,000 landed in Moranbah. So those are the fundamental basis of our forecast for financial year '26 where -- '27, where we see that $30 million to $70 million opportunity to keep growing our earnings year-on-year. I'll let Nitesh answer on corporate costs. And much of that has to do with some sticky stranded costs year-on-year to do with the divestment of fertilizers. But Nitesh will give you a bit more detail on the corporate costs.
Thanks, Mauro. Thanks, Ramoun, for the questions. Just to touch on your first half, second half split. As you know, we do have lots of weather impacts in our business. So we've used the basis of our long-term average. So that's an estimate from our side at this point in time. As far as corporate costs, we updated some of the offsets in our '26 results to demonstrate that we had approximately $5 billion impact this year. Next year, we also have the challenge of stranded costs as we've completed the fertilizer separation work. We are working through the IGNITE program or transformation program to ensure that some of our operational initiatives work hard to offset that. But largely, it's to do with stranded costs.
Okay. And any other, I guess, temporary factors that you've assumed for '27 that you expect to impact the results?
Yes. So Ramoun, on Slide 25, I think the 2 key ones to note is we've got a little bit of FX working against us, about $5 million. We have an average of $0.69 this year. And next year, we're planning for $0.70. We've also called out that included in our FY '27 transformation offsets $10 million related to scheduled maintenance at Moranbah. So that is separate to the turnarounds that we've called out specifically that impact our underlying result. That scheduled maintenance of $10 million in Moranbah, we've not taken it to underlying. We've just assumed that, that is part of the course of operations. It's scheduled and it's not a normal factor that we would experience every year. So that's 2 offsets to our program this year.
Okay. Got it. And while I've got you, maybe just on your leverage guide as well, that's also expected to come in at the top end of your range. Maybe just if you could talk through some of those factors. I guess, what's driving that higher CapEx number relative to expectations? And do your assumptions also make any allowance for contribution from Perdaman and the Geelong proceeds?
Yes. Thanks, Ramoun. So I think the main difference in terms of leverage being at a higher level is the -- to do with F separation. One major cash outflow in FY '27 is the Aero payment that we expect to make in FY '27. So that is -- the timing of that is obviously relevant versus some of the other proceeds that we expect from the F separation. So it's really the timing of some of the payments we're making in First separation, one on the Aero for Phosphate Hill. And second, some of the remediation work that we're doing in GI and Geelong and the timing of the expenses versus some of the proceeds that we're getting from the F separation is driving that temporary heightened level of leverage. We also need to note that this is a turnaround year for Cheyenne and some of our Energetics expenses are also proving to increase our capital expenditure and that leverage.
Your next question is from the line of Mark Wilson of RBC.
Just interested in some of the new contract wins that you've actually spoken to. Just sort of wondering if you could elaborate upon those and how material they are likely to be as we progress. And I also had a question about contract value being double that of fiscal '26. What does that actually mean? And how are you quantifying that?
Mark, thanks for the question. Look, the contract wins are really exciting because they play to many of our strategic directions, one being tying up with customers that already have business with us in other parts of the world. So case in point, AGA, who is a traditional customer of ours in Western Australia and also Vale, who has been doing business with us in Canada for some years and now giving us the opportunity to serve them in Brazil. It's all predicated on our Delta differential energy technology with electronic detonators. So proves the point of we win when we generate additional value through technology to our customers. Those are -- the site in Brazil is smallish. The sites in Africa are very large and provide us a good opportunity for earnings growth. They set operations in countries that have traditional mining operations, especially in Brazil, Ghana and Tanzania. So I would expect that once you have set up shop and establish an operation that would create pathway for further growth from there. In terms of the overall -- can you ask again the second question? Sorry, I lost my train of thought.
No, that's okay. Now just in relation to contract value, you've sort of put in there that it is fiscal '27, it's double that of fiscal '26. Just trying to understand how you are quantifying that. What does it all mean? And I'll add another one there. Where was that figure 12 months ago and 2 years ago?
This is something that we disclosed for the first time in our recent Investor Day, Mark. This is the size of our forward contract book. So the way we measure that is what is the revenue that we have contracted if you look the full business forward, divided by the revenues of our previous financial year. So essentially gives you a sense of the amount of forward revenue that's precontracted the business. Obviously, it varies from market to market, varies from customer to customer. So you have contracts ranging from 5 years in your metals mining customers typically to more like 1-year renewals in your car and construction in U.S. and you have everything in between. So with the 2 years, we try to give you a sense of the quality of our forward contract book. This is a new statistics that we provided for the first time in Investor Day, and that's something that we expect to keep informing the market as we're moving forward to keep a track of the quality of our ongoing contract book.
Your next question is from the line of Jakob Cakarnis of Jarden Australia.
I just wanted to pick up just on Mark's question there on Slide 23. Just on that forward contract value, can you break down maybe for us how much is price and mix versus volume just contributing to that, please?
Maybe I'll take this one, Jakob. So it's a combination of both. But the intention of this is less on the proportion of price and volume and more so the fact that this is the contract value that we have in our -- in commitments from our customers that is not reflected in our past earnings. So this is -- will come through as revenues, as contracted revenues into the future. It's a combination of, one, the commitment in the contract and the volume and price that we've already signed with those committed contracts. So it's bringing back Mauro's point around the quality of the investment proposition here at Dyno because we have a high quality of earnings, which is the contracted commitment that we have from our customers.
Okay. That was worth a shot. Just on the cash conversion. Obviously, there's some temporary issues in there, particularly around inventory builds and the like. And you've given us a sense of what it should look like next year. I mean when do we get to steady state on the working capital side of things and then cash conversion? Is that now from FY '27 and that's kind of the right 60% to 75% to think about moving forward, please?
Yes. And that's the intention. I know we've had lots of feedback from analysts and investors around the volatility around cash conversion. So going forward this year, we don't utilize working capital facilities, which have an impact on cash conversion historically as we had the fertilizers business. So going forward, we have a far more stable perspective on cash conversion, and it's consistent with the guidance I provided, which is in the 60% to 75% range from FY '27 onwards.
Okay. And then just the difference, Mauro, just in the growth assumed in the guidance range, it doubles the EBIT growth year-on-year between the low end and the high end. I think Ramoun kind of hinted on this. But what are the key moving parts for the differences in the assumed growth? Is it a matter of the turnarounds falling in that $25 million expectation? Or are there other items outside of that, please?
Well, look, it's just -- we're getting used to the idea of having earnings guidance, and we want to provide for a budget that has different levels of risk on the implementation. So those that we're calling out that are starting now, they are all in the base. So they are the contract wins that are already booked, and you should expect them to be cash flowing now in the first quarter of financial year. And in the other extreme on the high end, you have those where we have started commercial activity. The teams are confident. But again, you have a range of confidence levels. So as we do our budget, we try to have a center point where we look at those things that have decent likelihood. And then obviously, we allow for risks to the upside and downside. So there's nothing other than the natural success factor of our tender processes.
The next question is from the line of Lee Power of JPMorgan.
Just following on from Ramoun's question around the HQ and the outlook. I hear what you're saying, and it seems like your story is pretty consistent and you got the contract book commentary there. Like what are your customers actually telling you about the backdrop post the midterms, particularly in the U.S.
A great question, Lee. And look, we haven't seen -- it's probably too recent to tell, but we haven't seen any sign of change on the megatrends or any indication that the fundamentals that were driving them would change, whether it's in the defense energetics, whether it's in the AI investments. All indications, even pre the elections suggest that those things were in a way by pat, and you wouldn't see those fundamental changes about reshoring critical minerals or reestablishing sovereign capacity in ammunition. We don't see those things fundamentally change by either side of the aisle. But obviously, we'll keep an eye on that and report back as we see the progress.But so far, our bigger customers, many of which were represented on Investor Day, remain quite positive about the long-term outlook.
Okay. That's useful. And then just on launches, the energetic side, are there any differences in offtake contracting in Europe versus the U.S.? Like I'm thinking about things like are they take-or-pay commitments. Like how do you actually -- how do you think about the certainty of an offtake in Europe versus what you have in the U.S.?
It's a great question, Lee. We typically -- it will be a different model from the U.S. The U.S. model is what we call the GoCo where the government has invested in the facility and they naturally take all the needs they desire for their own capacity. Whilst in the Europe market where, first, you have multiple countries relying on capacity and they tend to not have the same scale as the U.S. comparatively. What typically happens is we would make the investment and then we would rely on offtake arrangements typically with the primes, the people that will be dealing with the different governments on their ammunition plans. So you would expect us to, in time, come with a number of offtake agreements with prime companies in Europe that would underline our investment in Vonges. So yes, it's difficult to say exactly the nature of that offtake if they would take the form of some joint venture arrangements, some partnership, some take-or-pay as you described, it's early to tell. But yes, it will be through the primes in Europe.
Your next question comes from Harry Saunders of E&P.
Firstly, just wondering with the weaker DNEL results, can you talk through your expectations for the business baked into the FY '27 guidance and contribution maybe to the $600 million target now, please?
Thanks, Harry. Look, I would say -- I'll start by saying '26 has been a disappointing year on DNEL, and we were very direct that we would expect for '26, a bigger contribution coming from the asset. There's probably 3 things that, as Nitesh pointed in his presentation, underline why we had somewhat disappointing results. The weakness on the French and Turkish infrastructure domestic market, much like the story of other European countries that saw infrastructure investment declining. We also had some difficulties exporting products out of Vonges into other markets in Europe, much driven by shortage of shipping given the trad of onus crisis. We would hope that those things reverse throughout this year, and we have a more normal base European business. And other than that, really, the growth that I outlined, whether it's from the new build Ilo plant in Peru, the start-up of Geita, Obuasi and Indoprien in Africa and the business in Brazil growing now with the first announced contract with Fabrica. So all those things give us confidence that financial year '27 should be a better year for DNEL, but we accept that the financial year '26 results were not what we expect.
Can you give us any more would we get back up to, say, '25 levels there or too early to tell?
We don't guide, Harry, by end market, but you should expect us to be reversing the reduction from this year. Okay. And just wondering on CapEx, how we should perhaps think about more normalized CapEx in '28 when delivering that $600 million of targeted EBIT.
Are we just pulling out the $40 million of turnaround CapEx this year or other things to consider there?
Thanks, Harry. I think when you look at some of the material we shared at our Investor Day, we would see CapEx intensity reducing over the next 5 years. So I think next year is kind of pulling back the turnaround spend for Cheyenne is key. We show a turnaround schedule in our appendix for some major and minor turnarounds. So that will help you on some of the longer-term outlooks as far as turnarounds are concerned. But generally, on the slide, we show that CapEx intensity from a CapEx to revenue basis was around 8%, and we would expect that to decline in the coming years.
Final question. Just if you could talk about how the supply-demand and pricing backdrop in your 2 main geographies panned out over the last 6 months, how it's currently tracking when you expect that North American tightness to persist until? And I mean, does the guidance anticipate sort of a headwind comping the one-off spot sales in '26? Or are you sort of expecting a similar benefit?
As I described earlier, Harry, we expect the ammonium nitrate market to remain very balanced. So we don't see the trends that we described earlier in the half year results reversing into financial year '27. The plant that was down in the U.S. is still not back. And to my best knowledge, there is no plan to bring it back in the short term. Obviously, the market finds new sources and there has been a number of imports into the U.S., which is not usual. And in the Australian market, there hasn't been any change. So you're still seeing import parity at Australian ports at around $9, $950 per tonne and then landed in Morombai at about $1,050. So look, that's the premise of our planning, really no major change from financial year '26, which was a strong year. Just as we grow in the U.S., we need to understand that some of the volumes that we serve in the U.S. is on trading. So we will have the tailwind of prices as we recontract new customers into the U.S., but we only take the short-term opportunity for any spot tons we have available. So obviously, that will be a consideration as we move forward. For traded tons, we are a price taker. And obviously, we don't have as much opportunity in that space, different from when we are trading our produced tons out of Cheyenne.
Your next question is from the line of Brook Campbell-Crawford with Barrenjoey.
I just have one on the $25 million estimated turnaround impact. Just want to check if that's a fairly locked-in number that wouldn't have much variance around it, maybe only a couple of million or if this is something that you needed to make some estimates around pricing and ammonia and the variance could be $5 million to $10 million or so around that $25 million estimate, that would be great.
Thanks, Brook. Look, we have been -- it's not the first time we are forecasting turnarounds. So I think we have some decent level of understanding of what that looks like. So I would say we have a good handle on that number. And that's essentially the Cheyenne plus the impacts of the Q&P turnaround that is also happening this year. As Nitesh said in his presentation, QNP and the other dozen or so JVs we have is an important part of our. So every time that one of those JVs have a one-off, it has an impact on our numbers. So yes, we have a good handle of those, and I don't expect that to be varying much outside this $25 million that we guided.
That's great. And just on market share, I mean, you guys seem to be winning more contracts than you're losing and there's lots of good anecdotes you provided today at your Investor Day. Is there a way you can sort of simplify it for us, maybe like a market share number that you would estimate you have at the moment and maybe comparing that to a couple of years ago perhaps before some of these gains started to flow through. Any color on that would be helpful.
Brook, this is -- as we disclose more, obviously, there's obviously an appetite for more and more information. So we do our best to give you a sense and give you data where it's relevant. I would say that especially on the growth markets, that's where I would put your attention. We told, for instance, that we have increased our metal revenue in Canada by about 40%. Some of that comes out of new operations, greenfields, brownfields, but also having won some contracts from our competitors. So those are areas where there is a material move in market share. Equally, those mines that we're taking up, whether it's in Brazil, whether it's in Africa and our enter in I and Peru, all the revenues coming out of those are new revenue that was being served by some competitor. So those are the areas to note and probably the areas where you should put your attention. In the mature markets, we have been very disciplined in price. We win on the basis of value creation. So we win some, we lose some, and we have seen some growth year-on-year. But fair to say, not as market as the markets that we highlighted in our presentation.
That's great. And then just one last quick one. Indonesia was a softer market in FY '26, I know it's not a huge market for you, but it was sort of one of the kind of weak points globally, I think, for all players. What's your assessment at the moment? Have conditions sort of recently picked up and looking better? Or do you think it's still going to remain pretty challenged in Indonesia for the year ahead?
Look, Stuart was there last week, and we have been investing in the country, including some emotion manufacturing with a partner. Our view of the market is it's firming up. I won't comment on the strength of the currency. Obviously, that has been a big factor for this past year. So it's really difficult to forecast what will happen. But those recent situations where they have done some export bans and which impacted the market to some extent, we've seen those things tempering down, and we expect a more normal year out of Indonesia.
Your next question is from the line of Niraj Shah of Goldman Sachs.
I might come at the DNEL question a different way. You've called out $35 million to $50 million priority growth markets in terms of the contribution to FY '27 transformation. I guess how much of that should go to DNEL versus, say, Canada, for example? And how much of that is underpinned by contracts you've already signed?
So again, you're asking the same question in a different way. I appreciate that, but we haven't guided by end market. Giving any guidance for us was a big step, Niraj. I think we'll probably stick to group level earnings guidance. But to your second question, think about the $35 million, the bottom of the range being the run rate of financial year '26 plus the ones that we have disclosed that are in the process of starting operations. So what we'd call low-risk growth. So we're pretty confident on those. And the top side of the range are activities, commercial activities that are underway with various degrees of probability. So we try to give you a range of success on our -- and typically, what we do is we put the low-risk growth opportunities in the bottom end and the more high-risk opportunities in the top range.
Fair enough. And just another quick one for me. On D&A, it looks like Q&C and metals held pretty solid momentum in the second half. But I could be wrong, but coal seems to have slowed a bit. I was just wondering if you could comment on that and how you're seeing that coal end market in the U.S. in particular, into FY '27.
Yes. I think your comparison is right. The way you're portraying that metals and quarry and construction have been strong year-on-year and half-on-half, not as strong as coal, which is not surprising. We saw coal having a bit of a comeback in the first half. And we described that some of that had to do with pre-stripping activity that people do in advance of resuming mining operations. We saw that now more tempered half-on-half. Year-on-year, it was a 10% growth for coal, which again is a change on a declining year-on-year trend that we've seen for a few years. But I agree with you that compared to quarry and construction in metals, not as impressive growth as we saw in those other 2 markets, which is not necessarily a bad thing. As you know, Niraj, comparatively, quarry and construction and metals are our best mix, give us the best yield, the best margins per ton. So we don't mind when the mix moves into more quarry and construction and metals.
Yes. Makes sense. And then final one for me. From memory, Kentucky TNT was still pending definitization before construction could commence. I guess in addition to the pre-engineering work, what sort of milestones need to be hit before you actually start construction on that TNT facility?
No, I'm happy to confirm that definitization is now complete, and we are starting construction early next calendar year. So it's all systems go in that space, Niraj.
And your next question is from the line of Scott Ryall of Primal Equity Research.
Nitesh, I'm just giving your heads up. My second question is going to be on Note 17 from your accounts, just so you can get that up. The first one is to Mauro. Mauro, you've set out the industry megatrends for the business. You've set out your investment priorities for the next year or 2, and you've stressed the investment discipline. If I look at Slide 25, which is where you've got the summary of the splits between the different geographic divisions. I was wondering if you could look out a little bit further on a kind of 3- to 5-year basis and just talk us through the investment decision-making that you're thinking about now just in terms of where the more attractive geographic markets are for you to invest for the longer term, please?
Thanks, Scott. Let me start answering your question in a different way. Let me tell you what we're not investing in. We're not investing in low returns, heavy infrastructure business like ammonium nitrate in the next 3 to 5 years. We believe the market long term is well balanced, and we need to return better returns on our existing infrastructure and play on capital-light growth opportunities, especially in markets where ammonium nitrate is naturally traded. And case in point, I made all this preamble to talk about things like Ilo in Peru. This is a growing market for mining globally. I have been there just a few months ago to cut the ribbon on our new emulsion plant. But when you think about a new ammonium nitrate plant, you're talking about probably $1.2 billion, $1.3 billion if you were to bring new capacity of the scale that we have. whilst a new emotion plant is about tens of millions of dollars. And as everyone else, you are importing ammonium nitrate in the country. So you're really competing on the base of technology, on the quality of emotion, on the quality of technology and not necessarily on having the molecule of AN, which in our view, is abundant globally and can be traded in these new growth markets. Now if I look at things like energetics and technology, that's probably the 2 areas that we are seeing potential opportunity. So starting with energetics, as I described in my presentation, we see Europe energetics doubling in the next 5 years, and there is a window of opportunity to fulfill that necessary growth that we'll see in the manufacturing capacity. Obviously, we'll do that in disciplined ways as -- as I got a question just a few minutes ago, we won't be doing that unless we have some security of supply and some understanding of offtake from people that are interested in the plants, and we'll have more to say about that in the next few months. Now in terms of technology, the thing that makes me most proud is when we make the investments over the years, and it pays back like what happened with the autonomous bench. We this year launched industry first ability to make autonomy a reality in the last moving part on the mining segment, which is the ability to do everything we do in a bench without any people involved. And that investment is now a reality starting to be tested next year in Mariana Minerals and with lots of interest of the big miners globally. To be honest, we have more demand than we can probably deal with in the short term. We're really now coming back to the drawing board to think about how we can accelerate the implementation of what has been a very successful launch. So think about technology, think about low capital emotion plants in growing markets, think about how we invest in energetics. Those are probably the main drivers of our growth beyond the sustaining growth of our existing operations.
Okay. And so it's not it's not any particular geography that you're seeing is attractive. It's more the end market and where you see the opportunities for those end markets you've just described. Is that a fair way of thinking about it?
Yes. I think about following our customers and following growth. So for instance, I don't want to discriminate against our mature markets because as much as they are mature, there's lots of growth in Asia Pacific and Americas. In case in point, places like Malaysia, where we've grown from nothing to a somewhat meaningful presence in quarry and construction or Canada that's grown year-on-year 40% in metals. So even the mature markets have lots of opportunity to continue growth. But fair to say that on a very low base, LatAm and Africa remain the biggest relative opportunities for us. So we are not shy to put down capital on -- and again, on the basis of tens of millions of dollars of emotion plants in places like Peru, in places like Brazil, in places like Ghana and Tanzania, those are likely to be disproportionately important given what's happening on the mining activity on those markets. But notwithstanding those growth markets, our more mature markets are not shy of opportunity in places like Canada and WA.
Okay. That's a really helpful answer. So I say you've got the provisions note up. I just -- I'm looking at the footnote #1 just on the Phosphate Hill sale agreement. Just after some confirmation as to the provisions and potential ongoing liability. Have you now ruled this off? So this payment that you've made, the $125 million of funding support for future rehabilitation and remediation, does that rule off Dyno's exposure to the Phosphate Hill please?
Yes, that obligation following the payment of that asset retirement obligation passes to Mayfair.
Okay. Great. So no kind of potential residual liability or anything like that as far as you're concerned?
I think when we concluded the sale, our assessment is that, that concludes our residual liability.
Your next question comes from the line of [ Ben Wedd ] of Macquarie.
Just a couple of quick ones from me. Just on the DNAP business there, any observations on Indonesian coal demand going into FY '27? I know you've detailed it was a pretty soft market in FY '26.
Ben, as I mentioned before, we expect the '27 situation to be normalized. So volume-wise, we expect the financial year '27 to be a normal year for us. As I said, difficult to comment on the translation impacts on Aussie dollars. But in terms of volume and price, we don't see any change year-on-year.
Yes. Great. And then also just looking -- thinking about the contract or recontracting cycle here. So what are your sort of expectations for pricing and predominantly speaking in the DNAP business into the next year? And maybe you can frame that in terms of what percentage of the contract book is up for renewal, if it's possible.
Yes. Thanks, Ben. Consistent to what I discussed before, we're not up for renewal next financial year. So we have -- and that's part of the 2 years contract life that we mentioned earlier today. But the DNAP sustaining price stays very healthy at about $1,000 landed in Moranbah in terms of import parity. I would say that if the conditions remain unchanged, I would expect that the next recontracting cycle would give us another opportunity to play catch up and to have another bite of the cherry, probably not as substantial as the last one where there was a correction, but there's still opportunity to get near that current spot price level.
And that concludes our Q&A session for today. I would like to turn the call back over to Mauro for closing remarks.
Thanks for your interest. I look forward to meeting many of you in the next few weeks as we go in our roadshow. I couldn't be prouder of the year we just finished. It was our first year giving earnings guidance to the market coming to full year, being able to report being squarely within the guidance, having just come out of Investor Day showing the capability of our team. And if I could just drop the last line here to thank everyone in Dyno Nobel for their efforts, team that wouldn't be possible with each of you. So now I'm speaking to the 25% of our workforce that has chosen to be with you, investors, part of the investors of our company. So my big thanks for the Dyno Nobel team and their efforts to bring together these results, and we are already in delivery mode for the next year. So thank you, everyone, and see you in the road.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Dyno Nobel Limited transcript - plus 260,000+ transcripts from 13,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Dyno Nobel Limited earnings transcripts and 260,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $145 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.